Urine immune profiling by measurement of multiple cytokine/chemokine mRNA levels in renal allograft dysfunction
Open Access
- 1 January 2011
- journal article
- Published by Scientific Research Publishing, Inc. in Open Journal of Immunology
- Vol. 01 (03), 87-96
- https://doi.org/10.4236/oji.2011.13011
Abstract
Background: An accurate diagnosis of cause of acute renal graft dysfunction is crucial for the optimal management of transplant recipients. Currently available tests are either insensitive or nonspecific, or are invasive, such as allograft biopsy. During last decade, attempts have been made in search of non invasive markers for the evaluation of cause of graft dysfunction. We studied a set of genes expressed on cytotoxic T Lymphocytes and those related to functioning of regulatory or helper T cells. Methods: We obtained 108 urine samples from 108 renal allograft recipients at the time of graft biopsy done for the evaluation of cause of graft dysfunction. RNA was extracted from urinary cells and messenger RNA (mRNA) encoding perforin, granzyme B (GB), FoxP3, CD3?, CXCR3, TGF-?, CTLA4, PI-9, IL-10, TNF?, T-bet and 18SrRNA measured with the use of quantitative real time polymerase chain reaction (RT-PCR). The levels of expression of genes were correlated with the biopsy findings and the results compared among different groups. Renal allograft biopsies at this institution are performed when there is unexplained rise in serum creatinine of >20% from the baseline value and reported according to Banff classification. SPSS v10.0 used for analy-sis.Results: The mRNA copy numbers of GB, Perforin, FoxP3, CD3, CXCR3, TGF-?, CTL A4, PI9, IL-10, TNF?, and T-bet were log transformed and mean (± SD) levels studied. The expression of all studied genes were compared between ‘nonspecific biopsy findings’ and other specific diagnoses. GB, Perforin, FoxP3, TGF-?, CD3?, CTLA4 CXCR3 and T-bet were higher in acute cellular rejection (ACR), whereas, TGF-? was also found higher in infection, and PI-9 in chronic allograft nephropathy (CAN) and borderline rejection group. Conclusion: Measurement of mRNA levels for genes like GB, Perforin, FoxP3, TGF-β, CD3?, CTLA4, CXCR3 and T-bet in urine samples offers a non invasive means of diag-nosing cause of graft dysfunctionKeywords
This publication has 33 references indexed in Scilit:
- Intragraft Levels of Foxp3 mRNA Predict Progression in Renal Transplants with Borderline ChangeJournal of the American Society of Nephrology, 2008
- Noninvasive Prediction of Organ Graft Rejection and Outcome Using Gene Expression PatternsTransplantation, 2008
- FOXP3 Expression in Human Kidney Transplant Biopsies Is Associated with Rejection and Time Post Transplant but Not with Favorable OutcomesAmerican Journal of Transplantation, 2008
- Pathological and Clinical Correlates of FOXP3+ Cells in Renal Allografts during Acute RejectionAmerican Journal of Transplantation, 2007
- Increased urinary excretion of transforming growth factor-β1 in renal transplant recipients during cytomegalovirus infectionTransplant Immunology, 2006
- Control of Effector CD8 + T Cell Function by the Transcription Factor EomesoderminScience, 2003
- Noninvasive Diagnosis of Renal-Allograft Rejection by Measurement of Messenger RNA for Perforin and Granzyme B in UrineThe New England Journal of Medicine, 2001
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- REGULATION OF IMMUNE RESPONSES BY TGF-βAnnual Review of Immunology, 1998
- Intracellular Trafficking of CTLA-4 and Focal Localization Towards Sites of TCR EngagementImmunity, 1996